Antinociceptive Effect of Intrathecal Nefopam and Interaction with Morphine in Formalin-Induced Pain of Rats
2
조회
0
다운로드
8
인용
0
참고문헌
키워드
초록
Background:Nefopam, a non-opiate analgesic, has been regarded as a substance that reduces the requirement for morphine, but conflicting results have also been reported. The inhibition of monoamine reuptake is a mechanism of action for the analgesia of nefopam. The spinal cord is an important site for the action of monoamines however, the antinociceptive effect of intrathecal nefopam was not clear. This study was performed to examine the antinociceptive effect of intrathecal (i.t.) nefopam and the pattern of pharmacologic interaction with i.t. morphine in the formalin test. Methods:Male Sprague-Dawley rats were implanted with an i.t. catheter, and were randomly treated with a vehicle, nefopam, or morphine. Formalin was injected into the hind-paw 10 min. after an i.t. injection of the above experiment drugs. After obtaining antinociceptive ED50 of nefopam and morphine, the mixture of nefopam and morphine was tested for the antinociceptive effect in the formalin test at a dose of 1/8, 1/4, 1/2 of ED50, or ED50 of each drug followed by an isobolographic analysis. Results:Intrathecal nefopam significantly reduced the flinching responses in both phases of the formalin test in a dose-dependent manner. Its effect, however, peaked at a dose of 30 mg in phase 1 (39.8% of control) and 10 mg during phase 2 (37.6% of control). The isobolograhic analysis indicated an additive interaction of nefopam and morphine during phase 2, and a synergy effect in antinociception during phase 1. Conclusions:This study demonstrated that i.t. nefopam produces an antinociceptive effect in formalin induced pain behavior during both phases of the formalin test, while interacting differently with i.t. morphine, synergistically during phase 1, and additively during phase 2.
Abstract
Background:Nefopam, a non-opiate analgesic, has been regarded as a substance that reduces the requirement for morphine, but conflicting results have also been reported. The inhibition of monoamine reuptake is a mechanism of action for the analgesia of nefopam. The spinal cord is an important site for the action of monoamines however, the antinociceptive effect of intrathecal nefopam was not clear. This study was performed to examine the antinociceptive effect of intrathecal (i.t.) nefopam and the pattern of pharmacologic interaction with i.t. morphine in the formalin test. Methods:Male Sprague-Dawley rats were implanted with an i.t. catheter, and were randomly treated with a vehicle, nefopam, or morphine. Formalin was injected into the hind-paw 10 min. after an i.t. injection of the above experiment drugs. After obtaining antinociceptive ED50 of nefopam and morphine, the mixture of nefopam and morphine was tested for the antinociceptive effect in the formalin test at a dose of 1/8, 1/4, 1/2 of ED50, or ED50 of each drug followed by an isobolographic analysis. Results:Intrathecal nefopam significantly reduced the flinching responses in both phases of the formalin test in a dose-dependent manner. Its effect, however, peaked at a dose of 30 mg in phase 1 (39.8% of control) and 10 mg during phase 2 (37.6% of control). The isobolograhic analysis indicated an additive interaction of nefopam and morphine during phase 2, and a synergy effect in antinociception during phase 1. Conclusions:This study demonstrated that i.t. nefopam produces an antinociceptive effect in formalin induced pain behavior during both phases of the formalin test, while interacting differently with i.t. morphine, synergistically during phase 1, and additively during phase 2.
참고문헌 (34)
- Heel RC, "Nefopam: a review of its pharmacological properties and therapeutic efficacy", Drugs, 19, pp.249~267 (1980)
- Fuller RW, "Evaluation of nefopam as a monoamine uptake inhibitor in vivo in mice", Neuropharmacology, 32, pp.995~999 (1993)
- Piercey MF, "Spinal and Supraspinal sites for morphine and nefopam analgesia in the mouse", Eur J Pharmacol, 74, pp.135~140 (1981)
- Evans MS, "Nefopam for the prevention of postoperative pain: quantitative systematic review", Br J Anaesth, 101, pp.610~617 (2008)
- Beaver WT, "A comparison of the analgesic effect of intramuscular nefopam and morphine in patients with postoperative pain", J Clin Pharmacol, 17, pp.579~591 (1977)
- McLintock TT, "Assessment of the analgesic efficacy of nefopam hydrochloride after upper abdominal surgery: a study using patient controlled analgesia", Br J Surg, 75, pp.779~781 (1988)
- Tramoni G, "Morphine- sparing effect of nefopam by continuous intravenous injection after abdominal surgery by laparotomy", Eur J Anaesthesiol, 20, pp.990~992 (2003)
- Moffat AC, "Postoperative nefopam and diclofenac. Evaluation of their morphine-sparing effect after upper abdominal surgery", Anaesthesia, 45, pp.302~305 (1990)
- Du Manoir B, "Randomized prospective study of the analgesic effect of nefopam after orthopaedic surgery", Br J Anaesth, 91, pp.836~841 (2003)
- Beloeil H, "The median effective dose of nefopam and morphine administered intravenously for postoperative pain after minor surgery: a prospective randomized double-blinded isobolographic study of their analgesic action", Anesth Analg, 98, pp.395~400 (2004)
- Richebé P, "Effects of nefopam on early postoperative hyperalgesia after cardiac surgery", J Cardiothorac Vasc Anesth (2012)
- Aveline C, "Postoperative analgesia and early rehabilitation after total knee replacement: a comparison of continuous low-dose intravenous ketamine versus nefopam", Eur J Pain, 13, pp.613~619 (2009)
- Bernatzky G, "Intrathecal injection of codeine, buprenorphine, tilidine, tramadol and nefopam depresses the tail-flick response in rats", Eur J Pharmacol, 120, pp.75~80 (1986)
- Fasmer OB, "Antinociceptive effects of (+", -)-, (+)- and (-)-nefopam in mice, 1987, pp.39, 508~511
- Millan MJ, "Descending control of pain", Prog Neurobiol, 66, pp.355~474 (2002)
- Yaksh TL, "Chronic catheterization of the spinal subarachnoid space", Physiol Behav, 17, pp.1031~1036 (1976)
- Coderre TJ, "The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury", J Neurosci, 12, pp.3665~3670 (1992)
- Tallarida RJ, "Drug synergism and dose-effect data analysis. 1st ed", pp.2000, Chapman & Hall
- Kehlet H, "The value of "multimodal" or "balanced analgesia" in postoperative pain treatment", Anesth Analg, 77, pp.1048~1056 (1993)
- Rosland JH, "The effect of nefopam and its enantiomers on the uptake of 5-hydroxytryptamine, noradrenaline and dopamine in crude rat brain synaptosomal preparations", J Pharm Pharmacol, 42, pp.437~438 (1990)
- Girard P, "Nefopam reduces thermal hypersensitivity in acute and postoperative pain models in the rat", Pharmacol Res, 44, pp.541~545 (2001)
- Girard P, "Nefopam potentiates morphine antinociception in allodynia and hyperalgesia in the rat", Pharmacol Biochem Behav, 77, pp.695~703 (2004)
- Buritova J, "Effects of nefopam on the spinal nociceptive processes: a c-Fos protein study in the rat", Eur J Pharmacol, 441, pp.67~74 (2002)
- Kapfer B, "Nefopam and ketamine comparably enhance postoperative analgesia", Anesth Analg, 100, pp.169~174 (2005)
- Elham Saghaei, "Enhancement of Antinociception by Co-administrations of Nefopam, Morphine, and Nimesulide in a Rat Model of Neuropathic Pain", The Korean Journal of Pain, 25(1), pp.7~15 (2012), 대한통증학회
- Girard P, "Systematic evaluation of the nefopam-paracetamol combination in rodent models of antinociception", Clin Exp Pharmacol Physiol, 38, pp.170~178 (2011)
- Girard P, "Nefopam and ketoprofen synergy in rodent models of antinociception", Eur J Pharmacol, 584, pp.263~271 (2008)
- Delage N, "Median effective dose (ED50) of nefopam and ketoprofen in postoperative patients: a study of interaction using sequential analysis and isobolographic analysis", Anesthesiology, 102, pp.1211~1216 (2005)
- Abbott FV, "The formalin test: scoring properties of the first and second phases of the pain response in rats", Pain, 60, pp.91~102 (1995)
- Rahman W, "Descending serotonergic facilitation mediated through rat spinal 5HT3 receptors is unaltered following carrageenan inflammation", Neurosci Lett, 361, pp.229~231 (2004)
- Green GM, "An excitatory role for 5-HT in spinal inflammatory nociceptive transmission; state-dependent actions via dorsal horn 5-HT(3) receptors in the anaesthetized rat", Pain, 89, pp.81~88 (2000)
- Verleye M, "Contribution of transient receptor potential vanilloid subtype 1 to the analgesic and antihyperalgesic activity of nefopam in rodents", Pharmacology, 83, pp.116~121 (2009)
- Girard P, "Modulation of paracetamol and nefopam antinociception by serotonin 5-HT(3) receptor antagonists in mice", Pharmacology, 83, pp.243~246 (2009)
- Verleye M, "Nefopam blocks voltage-sensitive sodium channels and modulates glutamatergic transmission in rodents", Brain Res, 1013, pp.249~255 (2004)